What is NDC 68788-7269?

68788-7269 is the product NDC for Liothyronine Sodium, Liothyronine sodium 5 ug/1 tablet, listed with the FDA by Preferred Pharmaceuticals Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.

Preferred Pharmaceuticals Inc., NDC labeler code 68788. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Liothyronine Sodium?

44 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Liothyronine Sodium NDC 68788-7269

NDC codes

FDA NDC Directory

Product NDC (as listed)68788-7269Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68788-7269Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
68788-7269-3	6878872690368788726903	30 TABLET in 1 BOTTLE (68788-7269-3)Marketed from Jan 11, 2019
68788-7269-6	6878872690668788726906	60 TABLET in 1 BOTTLE (68788-7269-6)Marketed from Jan 11, 2019
68788-7269-9	6878872690968788726909	90 TABLET in 1 BOTTLE (68788-7269-9)Marketed from Jan 11, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Liothyronine Sodium
Generic name (nonproprietary): liothyronine sodium
Active ingredients: Liothyronine sodium — 5 ug/1
Dosage form: Tablet
Route: Oral
Labeler: Preferred Pharmaceuticals Inc.NDC labeler code 68788
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 200295
Marketing start: Jan 11, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Triiodothyronine (Chemical structure)
Identifiers: Product ID 68788-7269_cb7904ed-91d9-47c1-8841-5cea1d5c9ed0SPL ID cb7904ed-91d9-47c1-8841-5cea1d5c9ed0SPL set ID 57744c7c-af44-4bc4-a5a8-79f05710f469RxCUI 903456UNII GCA9VV7D2N
Pharmacologic class: l-Triiodothyronine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468788726903 followed by a unit qualifier and the quantity

Package 68788-7269-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 22, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Liothyronine sodium is an L-triiodothyronine (T3) indicated for: • Hypothyroidism: As replacement in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism ( ) • Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of well-differentiated thyroid cancer ( ) • Thyroid Suppression Test: As a diagnostic agent in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy ( 1.3 ) Limitations of Use: - Not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients. ( 1 ) - Not in…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68788-7269

What is NDC 68788-7269?: 68788-7269 is the product NDC for Liothyronine Sodium, Liothyronine sodium 5 ug/1 tablet, listed with the FDA by Preferred Pharmaceuticals Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Liothyronine Sodium.
What is the active ingredient?: Liothyronine sodium.
Who is the labeler?: Preferred Pharmaceuticals Inc., NDC labeler code 68788. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Liothyronine Sodium?: 44 other product NDCs are listed under this name. See all Liothyronine Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Liothyronine Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Liothyronine Sodium	Liothyronine sodium 25 ug/1	TabletOral	Dr. Reddy's Labratories Inc.	75907-001	75907-0001-01
Liothyronine Sodium	Liothyronine sodium 50 ug/1	TabletOral	Dr. Reddy's Labratories Inc.	75907-004	75907-0004-01
Liothyronine Sodium	Liothyronine sodium 5 ug/1	TabletOral	Dr. Reddy's Labratories Inc.	75907-039	75907-0039-01
Liothyronine sodium	Liothyronine sodium 5 ug/1	TabletOral	Biocon Pharma Inc.	70377-114	70377-0114-1170377-0114-1270377-0114-13
Liothyronine sodium	Liothyronine sodium 25 ug/1	TabletOral	Biocon Pharma Inc.	70377-115	70377-0115-1170377-0115-1270377-0115-13
Liothyronine sodium	Liothyronine sodium 50 ug/1	TabletOral	Biocon Pharma Inc.	70377-116	70377-0116-1170377-0116-1270377-0116-13
Liothyronine sodium	Liothyronine sodium 5 ug/1	TabletOral	Northstar Rx LLC	16714-166	16714-0166-01
Liothyronine sodium	Liothyronine sodium 25 ug/1	TabletOral	Northstar Rx LLC	16714-167	16714-0167-01
Liothyronine sodium	Liothyronine sodium 50 ug/1	TabletOral	Northstar Rx LLC	16714-168	16714-0168-01
Liothyronine Sodium	Liothyronine sodium 25 ug/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0093-2178	00093-2178-01

All 45 Liothyronine Sodium NDCs

Other NDCs under ANDA 200295

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 200295
Product	Strength	Form · route	Labeler	Product NDC
Liomnyliothyronine sodium	Liothyronine sodium 5 ug/1	TabletOral	SIGMAPHARM LABORATORIES, LLC	42794-131
Liomnyliothyronine sodium	Liothyronine sodium 25 ug/1	TabletOral	SIGMAPHARM LABORATORIES, LLC	42794-132
Liomnyliothyronine sodium	Liothyronine sodium 50 ug/1	TabletOral	SIGMAPHARM LABORATORIES, LLC	42794-133
Liothyronine Sodium	Liothyronine sodium 5 ug/1	TabletOral	SIGMAPHARM LABORATORIES, LLC	42794-018
Liothyronine Sodium	Liothyronine sodium 25 ug/1	TabletOral	SIGMAPHARM LABORATORIES, LLC	42794-019
Liothyronine Sodium	Liothyronine sodium 50 ug/1	TabletOral	SIGMAPHARM LABORATORIES, LLC	42794-020
Liothyronine Sodium	Liothyronine sodium 25 ug/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	43063-884
Liothyronine Sodium	Liothyronine sodium 5 ug/1	TabletOral	A-S Medication Solutions	50090-3131
Liothyronine Sodium	Liothyronine sodium 5 ug/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-3571
Liothyronine Sodium	Liothyronine sodium 5 ug/1	TabletOral	Proficient Rx LP	71205-150
Liothyronine Sodium	Liothyronine sodium 25 ug/1	TabletOral	Bryant Ranch Prepack	71335-0166
Liothyronine Sodium	Liothyronine sodium 5 ug/1	TabletOral	Bryant Ranch Prepack	71335-0341
Liothyronine Sodium	Liothyronine sodium 50 ug/1	TabletOral	Bryant Ranch Prepack	71335-9632
Liothyronine Sodium	Liothyronine sodium 5 ug/1	TabletOral	ASCLEMED USA INC.	87063-080
Liothyronine Sodium	Liothyronine sodium 25 ug/1	TabletOral	ASCLEMED USA INC.	87063-081
Liothyronine Sodium	Liothyronine sodium 50 ug/1	TabletOral	ASCLEMED USA INC.	87063-082